about
sameAs
The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatmentNeurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functionsEndogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C diseaseNeurosteroid regulation of central nervous system developmentThe role of ovarian hormone-derived neurosteroids on the regulation of GABAA receptors in affective disordersShuyu Capsules Relieve Premenstrual Syndrome Depression by Reducing 5-HT3AR and 5-HT3BR Expression in the Rat Brain.Female reproductive steroids and neuronal excitabilityMenstrual cycle-related exacerbation of diseaseThe GABAergic deficit hypothesis of major depressive disorder.Tolerance to allopregnanolone with focus on the GABA-A receptor.Update on research and treatment of premenstrual dysphoric disorder.Estrogen- and progesterone-mediated structural neuroplasticity in women: evidence from neuroimaging.GABA(A)R plasticity during pregnancy: relevance to postpartum depression.Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder.Ovarian cycle-linked plasticity of δ-GABAA receptor subunits in hippocampal interneurons affects γ oscillations in vivo.Increased GABA(A) receptor ε-subunit expression on ventral respiratory column neurons protects breathing during pregnancy.Modulation of neurosteroid potentiation by protein kinases at synaptic- and extrasynaptic-type GABAA receptors.Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder.The neurosteroid 5β-pregnan-3α-ol-20-one enhances actions of etomidate as a positive allosteric modulator of α1β2γ2L GABAA receptorsMenstrual effects on mood symptoms in treated women with bipolar disorderDaily isoflurane exposure increases barbiturate insensitivity in medullary respiratory and cortical neurons via expression of ε-subunit containing GABA ARs.Lamotrigine and GABAA receptor modulators interact with menstrual cycle phase and oral contraceptives to regulate mood in women with bipolar disorder.Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.Disadaptive disorders in women: allopregnanolone, a sensitive steroid.Steroid hormone fluctuations and GABA(A)R plasticity.Postpartum depression and role of serum trace elements.The cerebellum as a target for estrogen action.Elevated gray matter volume of the emotional cerebellum in women with premenstrual dysphoric disorder.Extrasynaptic GABAA receptors in the crosshairs of hormones and ethanol.Drospirenone: a novel progestin.Estrous cycle regulation of extrasynaptic δ-containing GABA(A) receptor-mediated tonic inhibition and limbic epileptogenesisGlycine receptor in rat hippocampal and spinal cord neurons as a molecular target for rapid actions of 17-beta-estradiol.Insights into the structure and pharmacology of GABA(A) receptors.Neurosteroids and epileptogenesis.GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.Psychosocial Profile of Women with Premenstrual Syndrome and Healthy Controls: A Comparative Study.Severity of Premenstrual Symptoms Predicted by Second to Fourth Digit RatioIncreased Motor-Impairing Effects of the Neuroactive Steroid Pregnanolone in Mice with Targeted Inactivation of the GABAA Receptor γ2 Subunit in the Cerebellum.Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder.The antiepileptic effect of sodium valproate during different phases of the estrous cycle in PTZ-induced seizures in rats.
P2860
Q24561815-6A35794B-FEF2-4787-8CEA-4BD0E42B20B4Q24618586-20837DEB-475A-4DA1-93CF-6D7FA5E5967AQ24644950-BD1AE564-B736-4CB2-A5A3-B21B65F2E6F5Q24653847-E6A223E6-DCDB-4602-B293-B0DF547D0456Q26851296-58E0F2EA-1325-4ECD-B6A8-9DF0D03AEDACQ27349510-F406D783-CBF7-47AF-B26D-608E2D53639BQ28236577-B80EB05A-5007-478F-80D8-C5B67E6EE160Q30431992-F465B3AA-2921-441E-93B5-3548A9FC8C2CQ30464954-CD106C11-2BC0-481C-9ABF-2F63C48660DFQ30471700-17322452-FF77-4990-ACF8-D670F2D7286FQ30475462-4A418ABF-55D3-458E-BFF1-EE0DD7B59CCEQ31047972-4D59C101-FADB-46C9-BBFE-F95D0D263371Q33872187-FA52C5C1-7331-4A00-8700-83043140B312Q33919767-F1C44E23-55A6-422A-B3A1-8117047468E4Q34025794-8F4B2109-482B-46C3-90D2-5E7091D1AE66Q34251845-D49939CD-32B4-4F18-A3E4-E27A674967B7Q34550994-8AD37370-0BC0-40EF-B9BE-F27125620C9AQ34645878-E33B0B76-3443-48B2-BB0B-AE3F0D01D7E3Q34953451-AB300A89-101E-42D2-93FF-B2C14EDE3504Q35051425-8C5342AE-1375-43F0-A942-2F45F1A7E168Q35154667-C557E332-36E1-4ED9-B410-FFB20DADE366Q35155900-BBD9A224-01C2-4823-9382-100C5D0E8D42Q35681226-8CD7DCBA-7C05-4517-961C-07E94F4F99E0Q36051183-BC188EDA-495F-4D18-9B9B-251A0DFC717DQ36101683-4FF3E307-57E0-46DD-A941-1036698054D6Q36198077-02AFCC39-9983-42B6-8CFC-481FBBC9F57FQ36392945-46FB6533-6752-4489-B852-B174B1B6BC60Q36487232-0F01C65E-6345-4C72-A101-818B6CAA7C4FQ36537052-ECDF168E-D5C1-486D-BDC4-EC4C06932849Q36808051-187FC862-C3C3-44B1-999B-58075EE4067CQ36935313-23010D24-BBE0-4289-91A2-1C9817AA84B6Q37117223-93E05D97-C3A4-4320-BE88-6484148F4419Q37855931-8C929D10-A5E1-4C2D-ADC2-3FA6D1CF1F66Q38114139-A5CCBD59-690F-40B4-8042-0B6EC8BB53C2Q38591320-C52F7670-B4D4-405A-AE58-E51EBF8456D1Q38870795-DB730D96-CE21-4EBB-B649-19C50727A89BQ41238384-DB80009D-D1A9-44FC-9FA6-C28E083DE7EFQ41586786-9B74B5EF-CA89-4E63-8F9F-6EAB4278F662Q43267026-903E3290-B0A4-46EF-BE56-CCE55C5BF19CQ45085798-5025F33B-CC1A-4577-B140-885B6017B4F3
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pathogenesis in menstrual cycle-linked CNS disorders
@ast
Pathogenesis in menstrual cycle-linked CNS disorders
@en
Pathogenesis in menstrual cycle-linked CNS disorders
@nl
type
label
Pathogenesis in menstrual cycle-linked CNS disorders
@ast
Pathogenesis in menstrual cycle-linked CNS disorders
@en
Pathogenesis in menstrual cycle-linked CNS disorders
@nl
altLabel
Pathogenesis in Menstrual Cycle-Linked CNS Disorders
@en
prefLabel
Pathogenesis in menstrual cycle-linked CNS disorders
@ast
Pathogenesis in menstrual cycle-linked CNS disorders
@en
Pathogenesis in menstrual cycle-linked CNS disorders
@nl
P2093
P2860
P50
P3181
P356
P1476
Pathogenesis in Menstrual Cycle-Linked CNS Disorders
@en
Pathogenesis in menstrual cycle-linked CNS disorders
@en
P2093
Agneta Andersson
Anna-Carin Wihlbäck
Charlott Lindblad
David Haage
Elisabeth Zingmark
Göran Wahlström
INGA-STINA ÖDMARK
Inga-Maj Johansson
Inger Björn
P2860
P3181
P356
10.1196/ANNALS.1286.005
P407
P577
2003-12-01T00:00:00Z